Literature DB >> 24474896

Whither advanced therapy medicinal products?

Mark D Smith1, Jan C Brune1, Britt Wildemann2, Axel Pruss3.   

Abstract

Year:  2013        PMID： 24474896      PMCID： PMC3901618          DOI： 10.1159/000356514

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  2 in total

1.  Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive.

Authors:  Romaldas Maciulaitis; Lucia D'Apote; Andrew Buchanan; Laura Pioppo; Christian K Schneider
Journal:  Mol Ther       Date:  2012-03       Impact factor: 11.454

2.  Trading on hope.

Authors:  Jane Qiu
Journal:  Nat Biotechnol       Date:  2009-09       Impact factor: 54.908
  2 in total
  2 in total

1.  Advanced therapy medicinal products - a multiple challenge.

Authors:  Axel Pruss; Henk Garritsen
Journal:  Transfus Med Hemother       Date:  2013-12       Impact factor: 3.747

2.  In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies.

Authors:  Christiane Broichhausen; Paloma Riquelme; Norbert Ahrens; Anja K Wege; Gudrun E Koehl; Hans J Schlitt; Bernhard Banas; Fred Fändrich; Edward K Geissler; James A Hutchinson
Journal:  Mol Ther Methods Clin Dev       Date:  2014-07-16       Impact factor: 6.698
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.